Sanara MedTech Inc. (SMTI)
Automate Your Wheel Strategy on SMTI
With Tiblio's Option Bot, you can configure your own wheel strategy including SMTI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SMTI
- Rev/Share 10.6848
- Book/Share 1.5293
- PB 6.7493
- Debt/Equity 1.2195
- CurrentRatio 2.7741
- ROIC -0.1325
- MktCap 256681108.0
- FreeCF/Share -0.2701
- PFCF -110.9047
- PE -21.6586
- Debt/Assets 0.7511
- DivYield 0
- ROE -0.2901
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | SMTI | H.C. Wainwright | -- | Buy | $50 | $51 | March 26, 2025 |
| Initiation | SMTI | H.C. Wainwright | -- | Buy | -- | $50 | Dec. 23, 2024 |
News
Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman, Chief Executive Officer Seth Yon - President, Chief Commercial Officer Sam Muppalla - President, Chief Executive Officer of Tissue Health Plus Elizabeth Taylor - Chief Financial Officer Conference Call Participants Matt Park - Cantor Fitzgerald Operator Welcome to the Sanara MedTech First Quarter of 2025 Earnings Conference Call. Please note that this conference call is being recorded and a replay will be available on the Investor Relations page of the company's website shortly.
Read More
Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Negative
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.21 per share a year ago.
Read More
Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Sanara MedTech (SMTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)
Published: March 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
Q4 Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year FORT WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary ● Net revenue increased 49% to $26.3 million, compared to $17.7 million in the fourth quarter of 2023.
Read More
About Sanara MedTech Inc. (SMTI)
- IPO Date 1994-04-07
- Website https://sanaramedtech.com
- Industry Medical - Instruments & Supplies
- CEO Mr. Ronald T. Nixon
- Employees 141